Literature DB >> 35653038

Patient-Centered Core Impact Sets: What They are and Why We Need Them.

Eleanor M Perfetto1,2, Elisabeth M Oehrlein1, T Rosie Love3, Silke Schoch1, Annie Kennedy4, Jennifer Bright5.   

Abstract

A quote attributed to Mark Twain states, "What gets us into trouble is not what we don't know. It's what we know for sure that just ain't so." The growing focus on patient centricity has revealed a misalignment between what patients report as important to them about their disease and/or treatment, and the data collected in research and care. Decisions across healthcare are made using an evidence base most stakeholders acknowledge is inadequate. Patients might report that what is important to them are everyday life impacts, concepts that can be very different from the more typical clinical outcomes we often track. In this paper, we encourage expanding current thinking to all "impacts," not only health outcomes, but also the other equally (and sometimes more important) concerns patients report as important to them. We propose that a patient-centered core impact set be developed for each disease or condition of interest, and/or subpopulation of patients. A patient-centered core impact set begins with gathering from patients and caregivers an inventory of all impacts disease and treatments have on a patient's (and carers' and families') life. Then, through a formal prioritization process, a core set of impacts is derived, inclusive of but extending beyond relevant health outcomes. We offer several recommendations on how to move the goal of a patient-centered core impact set forward through collaboration, leadership, and establishment of a patient-centered core impact set development blueprint with supporting tools.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35653038      PMCID: PMC9584872          DOI: 10.1007/s40271-022-00583-x

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.481


  42 in total

1.  Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015.

Authors:  Cynthia Gagnon; Chad Heatwole; Luc J Hébert; Jean-Yves Hogrel; Luc Laberge; Mario Leone; Giovanni Meola; Louis Richer; Valeria Sansone; Marie Kierkegaard
Journal:  J Neuromuscul Dis       Date:  2018

2.  Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology.

Authors:  A Alioum; F Dabis; L Dequae-Merchadou; G Haverkamp; M Hudgens; J Hughes; J Karon; V Leroy; M L Newell; B Richardson; G J Weverling
Journal:  Stat Med       Date:  2001-12-15       Impact factor: 2.373

3.  Value to Whom? The Patient Voice in the Value Discussion.

Authors:  Eleanor M Perfetto; Elisabeth M Oehrlein; Marc Boutin; Sarah Reid; Eric Gascho
Journal:  Value Health       Date:  2017-02       Impact factor: 5.725

4.  Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.

Authors:  Maarten Boers; John R Kirwan; George Wells; Dorcas Beaton; Laure Gossec; Maria-Antonietta d'Agostino; Philip G Conaghan; Clifton O Bingham; Peter Brooks; Robert Landewé; Lyn March; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell
Journal:  J Clin Epidemiol       Date:  2014-02-28       Impact factor: 6.437

Review 5.  Patient value: Perspectives from the advocacy community.

Authors:  Bonnie J Addario; Ana Fadich; Jesme Fox; Linda Krebs; Deborah Maskens; Kathy Oliver; Erin Schwartz; Gilliosa Spurrier-Bernard; Timothy Turnham
Journal:  Health Expect       Date:  2017-09-20       Impact factor: 3.377

6.  Defining and evaluating novel procedures for involving patients in Core Outcome Set research: creating a meaningful long list of candidate outcome domains.

Authors:  Harriet Smith; Adele Horobin; Kathryn Fackrell; Veronica Colley; Brian Thacker; Deborah A Hall
Journal:  Res Involv Engagem       Date:  2018-03-02

Review 7.  To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases.

Authors:  Sally Lanar; Catherine Acquadro; James Seaton; Isabelle Savre; Benoit Arnould
Journal:  Orphanet J Rare Dis       Date:  2020-06-03       Impact factor: 4.123

8.  Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus.

Authors:  Susanna Dodd; Nicola Harman; Nichole Taske; Mark Minchin; Toni Tan; Paula R Williamson
Journal:  Trials       Date:  2020-06-25       Impact factor: 2.279

Review 9.  Patient-Led Research Collaborative: embedding patients in the Long COVID narrative.

Authors:  Lisa McCorkell; Gina S Assaf; Hannah E Davis; Hannah Wei; Athena Akrami
Journal:  Pain Rep       Date:  2021-04-13

Review 10.  How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis.

Authors:  Joanne Greenhalgh; Kate Gooding; Elizabeth Gibbons; Sonia Dalkin; Judy Wright; Jose Valderas; Nick Black
Journal:  J Patient Rep Outcomes       Date:  2018-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.